{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:09:21Z","timestamp":1791425361060,"version":"4.3.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T00:00:00Z","timestamp":1171497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T00:00:00Z","timestamp":1171497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1038\/sj.leu.2404544","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T08:05:01Z","timestamp":1171526701000},"page":"697-705","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients"],"prefix":"10.1038","volume":"21","author":[{"given":"I","family":"Ricca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Drandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Francese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Compagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Lobetti Bodoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Astolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Monitillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Vallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Calvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Ficara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Omed\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Rosato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gallamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Marinone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Bergui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Boccadoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Tarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ladetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,2,15]]},"reference":[{"key":"BF2404544_CR1","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1056\/NEJM199805213382104","volume":"338","author":"G Dighiero","year":"1998","unstructured":"Dighiero G, Maloum K, Desablens B, Cazin B, Navarro M, Leblay R et al. Chlorambucil in indolent chronic lymphocytic leukemia. French cooperative group on chronic lymphocytic leukemia. N Engl J Med 1998; 338: 1506\u20131514.","journal-title":"N Engl J Med"},{"key":"BF2404544_CR2","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1182\/blood-2003-07-2281","volume":"103","author":"TD Shanafelt","year":"2004","unstructured":"Shanafelt TD, Geyer SM, Kay NE . Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood 2004; 103: 1202\u20131210.","journal-title":"Blood"},{"key":"BF2404544_CR3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"KR Rai","year":"1975","unstructured":"Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS . Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219\u2013234.","journal-title":"Blood"},{"issue":"1","key":"BF2404544_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1182\/asheducation-2003.1.153","volume":"2003","author":"M. J. Keating","year":"2003","unstructured":"Keating MJ, Chiorazzi N, Messmer B, Damle RN, Allen SL, Rai KR et al. Biology and treatment of chronic lymphocytic leukemia. Hematology (Am Soc Hematol Educ Program) 2003, 153\u2013175.","journal-title":"Hematology"},{"key":"BF2404544_CR5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1182\/blood-2005-04-1677","volume":"107","author":"JL Binet","year":"2006","unstructured":"Binet JL, Caligaris-Cappio F, Catovsky D, Cheson B, Davis T, Dighiero G et al. Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia. Blood 2006; 107: 859\u2013861.","journal-title":"Blood"},{"key":"BF2404544_CR6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.hoc.2004.04.003","volume":"18","author":"S Stilgenbauer","year":"2004","unstructured":"Stilgenbauer S, D\u00f6hner H . Molecular genetics and its clinical relevance. Hematol Oncol Clin North Am 2004; 18: 827\u2013848.","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF2404544_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","volume":"48","author":"JL Binet","year":"1981","unstructured":"Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198\u2013206.","journal-title":"Cancer"},{"key":"BF2404544_CR8","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H D\u00f6hner","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A, Leupolt E, Kr\u00f6ber A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910\u20131916.","journal-title":"N Engl J Med"},{"key":"BF2404544_CR9","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840\u20131847.","journal-title":"Blood"},{"key":"BF2404544_CR10","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1056\/NEJMoa023143","volume":"348","author":"M Crespo","year":"2003","unstructured":"Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 1764\u20131775.","journal-title":"N Engl J Med"},{"key":"BF2404544_CR11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa040857","volume":"351","author":"LZ Rassenti","year":"2004","unstructured":"Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004; 351: 893\u2013901.","journal-title":"N Engl J Med"},{"key":"BF2404544_CR12","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK . Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848\u20131854.","journal-title":"Blood"},{"key":"BF2404544_CR13","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","volume":"99","author":"TJ Hamblin","year":"2002","unstructured":"Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002; 99: 1023\u20131029.","journal-title":"Blood"},{"key":"BF2404544_CR14","first-page":"1259","volume":"88","author":"VM Duke","year":"2003","unstructured":"Duke VM, Gandini D, Sherrington PD, Lin K, Heelan B, Amlot P et al. V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia. Haematologica 2003; 88: 1259\u20131271.","journal-title":"Haematologica"},{"key":"BF2404544_CR15","first-page":"275","volume":"252","author":"A Migliazza","year":"2000","unstructured":"Migliazza A, Cayanis E, Bosch-Albareda F, Komatsu H, Martinotti S, Toniato E et al. Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions. Curr Top Microbiol Immunol 2000; 252: 275\u2013284.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BF2404544_CR16","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.1038\/sj.onc.1204640","volume":"20","author":"R Kuppers","year":"2001","unstructured":"Kuppers R, Dalla-Favera R . Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 2001; 20: 5580\u20135594.","journal-title":"Oncogene"},{"key":"BF2404544_CR17","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1038\/sj.leu.2403537","volume":"18","author":"D Capello","year":"2004","unstructured":"Capello D, Guarini A, Berra E, Mauro FR, Rossi D, Ghia E et al. Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia. Leukemia 2004; 18: 1941\u20131947.","journal-title":"Leukemia"},{"key":"BF2404544_CR18","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1182\/blood-2003-12-4412","volume":"103","author":"M Ladetto","year":"2004","unstructured":"Ladetto M, Compagno M, Ricca I, Pagano M, Rocci A, Astolfi M et al. Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders. Blood 2004; 103: 4644\u20134649.","journal-title":"Blood"},{"key":"BF2404544_CR19","first-page":"4918","volume":"58","author":"OE Bechter","year":"1998","unstructured":"Bechter OE, Eisterer W, Pall G, Hilbe W, Kuhr T, Thaler J . Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia. Cancer Res 1998; 58: 4918\u20134922.","journal-title":"Cancer Res"},{"key":"BF2404544_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/sj.bjc.6600763","volume":"88","author":"M Hultdin","year":"2003","unstructured":"Hultdin M, Rosenquist R, Thunberg U, Tobin G, Norrback KF, Johnson A et al. Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications. Br J Cancer 2003; 88: 593\u2013598.","journal-title":"Br J Cancer"},{"key":"BF2404544_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1182\/blood-2003-04-1345","volume":"103","author":"RN Damle","year":"2004","unstructured":"Damle RN, Batliwalla FM, Ghiotto F, Valetto A, Albesiano E, Sison C et al. Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations. Blood 2004; 103: 375\u2013382.","journal-title":"Blood"},{"key":"BF2404544_CR22","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1182\/blood-2004-11-4394","volume":"105","author":"P Grabowski","year":"2005","unstructured":"Grabowski P, Hultdin M, Karlsson K, Tobin G, leskog A, Thunberg U et al. Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status. Blood 2005; 105: 4807\u20134812.","journal-title":"Blood"},{"key":"BF2404544_CR23","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835\u20133849.","journal-title":"J Clin Oncol"},{"key":"BF2404544_CR24","first-page":"1640","volume":"8","author":"E Matutes","year":"1994","unstructured":"Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH et al. The immunological profile of B cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640\u20131645.","journal-title":"Leukemia"},{"key":"BF2404544_CR25","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/sj.leu.2403652","volume":"19","author":"I Ricca","year":"2005","unstructured":"Ricca I, Compagno M, Ladetto M, Rocci A, Dell\u2019Aquila M, Omed\u00e8 P et al. Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF. Leukemia 2005; 19: 644\u2013651.","journal-title":"Leukemia"},{"key":"BF2404544_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1083-8791(00)70006-1","volume":"6","author":"M Ladetto","year":"2000","unstructured":"Ladetto M, Donovan JW, Harig S, Trojan A, Poor C, Schlossnan R et al. Real-Time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma. Biol Blood Marrow Transplant 2000; 6: 241\u2013253.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF2404544_CR27","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood.V95.8.2651","volume":"95","author":"JW Donovan","year":"2000","unstructured":"Donovan JW, Ladetto M, Zou G, Neuberg D, Poor C, Bowers D et al. Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia. Blood 2000; 95: 2651\u20132658.","journal-title":"Blood"},{"key":"BF2404544_CR28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0301-472X(02)00794-4","volume":"30","author":"M Ladetto","year":"2002","unstructured":"Ladetto M, Omede P, Sametti S, Donovan JW, Astolfi M, Drandi D et al. Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvests. Exp Hematol 2002; 30: 529\u2013536.","journal-title":"Exp Hematol"},{"key":"BF2404544_CR29","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/sj.leu.2400801","volume":"11","author":"C Voena","year":"1997","unstructured":"Voena C, Ladetto M, Astolfi M, Provan D, Gribben JG, Boccadoro M et al. A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors. Leukemia 1997; 11: 1793\u20131798.","journal-title":"Leukemia"},{"key":"BF2404544_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/sj.leu.2402339","volume":"16","author":"J Durig","year":"2002","unstructured":"Durig J, Naschar M, Schmucker U, Renzing-Kohler K, Holter T, Huttmann A et al. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Leukemia 2002; 16: 30\u201335.","journal-title":"Leukemia"},{"key":"BF2404544_CR31","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood.V89.7.2516","volume":"89","author":"H D\u00f6hner","year":"1997","unstructured":"D\u00f6hner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997; 89: 2516\u20132522.","journal-title":"Blood"},{"key":"BF2404544_CR32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","volume":"39","author":"MH Zweig","year":"1993","unstructured":"Zweig MH, Campbell G . Receiver-Operating Characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561\u2013577.","journal-title":"Clin Chem"},{"key":"BF2404544_CR33","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/sj.leu.2403707","volume":"19","author":"R Schroers","year":"2005","unstructured":"Schroers R, Griesinger F, Tr\u00fcmper L, Haase D, Kulle B, Klein-Hitpass L et al. Combined analysis of Zap-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 2005; 19: 750\u2013758.","journal-title":"Leukemia"},{"key":"BF2404544_CR34","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1182\/blood-2004-01-0132","volume":"104","author":"G Tobin","year":"2004","unstructured":"Tobin G, Thunberg U, Karlsson K, Murray F, Laurell A, Willander K et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004; 104: 2879\u20132885.","journal-title":"Blood"},{"key":"BF2404544_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1182\/blood-2004-10-4073","volume":"06","author":"S Falt","year":"2005","unstructured":"Falt S, Merup M, Tobin G, Thunberg U, Gahrton G, Rosenquist R et al. Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia. Blood 2005; 06: 681\u2013689.","journal-title":"Blood"},{"key":"BF2404544_CR36","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1200\/JCO.2005.03.7184","volume":"24","author":"A Kr\u00f6ber","year":"2006","unstructured":"Kr\u00f6ber A, Bloehdorn J, Hafner S, Buhler A, Seiler T, Kienle D et al. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia. J Clin Oncol 2006; 24: 969\u2013975.","journal-title":"J Clin Oncol"},{"key":"BF2404544_CR37","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1182\/blood-2003-05-1549","volume":"103","author":"P Dreger","year":"2004","unstructured":"Dreger P, Stilgenbauer S, Benner A, Ritgen M, Krober A, Kneba M et al. The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status. Blood 2004; 103: 2850\u20132858.","journal-title":"Blood"},{"key":"BF2404544_CR38","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1200\/JCO.2005.04.531","volume":"23","author":"C Moreno","year":"2005","unstructured":"Moreno C, Villamor N, Colomer D, Esteve J, Martino R, Nomdedeu J et al. Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemia. J Clin Oncol 2005; 23: 3433\u20133438.","journal-title":"J Clin Oncol"},{"key":"BF2404544_CR39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4049\/jimmunol.158.1.235","volume":"158","author":"TA Johnson","year":"1997","unstructured":"Johnson TA, Rassenti LZ, Kipps TJ . Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 1997; 158: 235\u2013246.","journal-title":"J Immunol"},{"key":"BF2404544_CR40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/cyto.b.20133","volume":"70","author":"A Bojarska-Junak","year":"2006","unstructured":"Bojarska-Junak A, Giannopoulos K, Kowal M, Dmoszynska A, Rolinski J . Comparison of methods for determining zeta-chain associated protein \u2013 70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL). Cytometry B Clin Cytom 2006; 70: 293\u2013301.","journal-title":"Cytometry B Clin Cytom"},{"key":"BF2404544_CR41","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1054\/bjoc.1999.0970","volume":"82","author":"K Remes","year":"2000","unstructured":"Remes K, Norrback KF, Rosenquist R, Mehle C, Lindh J, Roos G . Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. Br J Cancer 2000; 82: 601\u2013607.","journal-title":"Br J Cancer"},{"key":"BF2404544_CR42","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1034\/j.1600-0609.2003.00157.x","volume":"71","author":"A Cottliar","year":"2003","unstructured":"Cottliar A, Pedrazzini E, Corrado C, Engelberger MI, Narbaitz M, Slavutsky I . Telomere shortening in patients with plasma cell disorders. Eur J Haematol 2003; 71: 334\u2013340.","journal-title":"Eur J Haematol"},{"key":"BF2404544_CR43","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1182\/blood-2002-11-3451","volume":"101","author":"KD Wu","year":"2003","unstructured":"Wu KD, Orme LM, Shaughnessy Jr J, Jacobson J, Barlogie B, Moore MA . Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival. Blood 2003; 101: 4982\u20134989.","journal-title":"Blood"},{"key":"BF2404544_CR44","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/ncb985","volume":"5","author":"LL Smith","year":"2003","unstructured":"Smith LL, Coller HA, Roberts JM . Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 2003; 5: 474\u2013479.","journal-title":"Nat Cell Biol"},{"key":"BF2404544_CR45","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/sj.leu.2402922","volume":"17","author":"VH van der Velden","year":"2003","unstructured":"van der Velden VH, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJ . Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approches and laboratory aspects. Leukemia 2003; 17: 1013\u20131034.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404544","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T18:23:08Z","timestamp":1683742988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,15]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["BF2404544"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404544","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,15]]},"assertion":[{"value":"2 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}